» Articles » PMID: 37180014

Nanomaterials for Photothermal Cancer Therapy

Overview
Journal RSC Adv
Specialty Chemistry
Date 2023 May 14
PMID 37180014
Authors
Affiliations
Soon will be listed here.
Abstract

Cancer has emerged as a pressing global public health issue, and improving the effectiveness of cancer treatment remains one of the foremost challenges of modern medicine. The primary clinical methods of treating cancer, including surgery, chemotherapy and radiotherapy, inevitably result in some adverse effects on the body. However, the advent of photothermal therapy offers an alternative route for cancer treatment. Photothermal therapy relies on photothermal agents with photothermal conversion capability to eliminate tumors at high temperatures, which offers advantages of high precision and low toxicity. As nanomaterials increasingly play a pivotal role in tumor prevention and treatment, nanomaterial-based photothermal therapy has gained significant attention owing to its superior photothermal properties and tumor-killing abilities. In this review, we briefly summarize and introduce the applications of common organic photothermal conversion materials (, cyanine-based nanomaterials, porphyrin-based nanomaterials, polymer-based nanomaterials, ) and inorganic photothermal conversion materials (, noble metal nanomaterials, carbon-based nanomaterials, ) in tumor photothermal therapy in recent years. Finally, the problems of photothermal nanomaterials in antitumour therapy applications are discussed. It is believed that nanomaterial-based photothermal therapy will have good application prospects in tumor treatment in the future.

Citing Articles

A Mo-doped carbon dot nanozyme for enhanced phototherapy .

Wang W, Sheng X, Wang Y, Yu M, Shen Y, Xia Y Nanoscale Adv. 2025; .

PMID: 40012580 PMC: 11851171. DOI: 10.1039/d5na00028a.


Magnetic-Plasmonic Core-Shell Nanoparticles: Properties, Synthesis and Applications for Cancer Detection and Treatment.

Rodriguez-Nieves A, Shah S, Taylor M, Alle M, Huang X Nanomaterials (Basel). 2025; 15(4).

PMID: 39997827 PMC: 11858323. DOI: 10.3390/nano15040264.


Preclinical advance in nanoliposome-mediated photothermal therapy in liver cancer.

Tang L, Yang X, He L, Zhu C, Chen Q Lipids Health Dis. 2025; 24(1):31.

PMID: 39891269 PMC: 11783920. DOI: 10.1186/s12944-024-02429-x.


Tongue squamous cell carcinoma-targeting Au-HN-1 nanosystem for CT imaging and photothermal therapy.

Hao M, Li X, Zhang X, Tao B, Shi H, Wu J Int J Oral Sci. 2025; 17(1):9.

PMID: 39805836 PMC: 11729884. DOI: 10.1038/s41368-024-00343-7.


A Novel Approach for Bladder Cancer Treatment: Nanoparticles as a Drug Delivery System.

Zhao X, Qi X, Liu D, Che X, Wu G Int J Nanomedicine. 2024; 19:13461-13483.

PMID: 39713223 PMC: 11662911. DOI: 10.2147/IJN.S498729.


References
1.
Shen J, Zhang W, Qi R, Mao Z, Shen H . Engineering functional inorganic-organic hybrid systems: advances in siRNA therapeutics. Chem Soc Rev. 2018; 47(6):1969-1995. PMC: 5861001. DOI: 10.1039/c7cs00479f. View

2.
Zhi D, Yang T, Yang J, Fu S, Zhang S . Targeting strategies for superparamagnetic iron oxide nanoparticles in cancer therapy. Acta Biomater. 2019; 102:13-34. DOI: 10.1016/j.actbio.2019.11.027. View

3.
Tang L, Li J, Pan T, Yin Y, Mei Y, Xiao Q . Versatile carbon nanoplatforms for cancer treatment and diagnosis: strategies, applications and future perspectives. Theranostics. 2022; 12(5):2290-2321. PMC: 8899561. DOI: 10.7150/thno.69628. View

4.
Yin B, Ho W, Xia X, Chan C, Zhang Q, Ng Y . A Multilayered Mesoporous Gold Nanoarchitecture for Ultraeffective Near-Infrared Light-Controlled Chemo/Photothermal Therapy for Cancer Guided by SERS Imaging. Small. 2023; 19(6):e2206762. DOI: 10.1002/smll.202206762. View

5.
Li C, Yang X, An J, Cheng K, Hou X, Zhang X . A near-infrared light-controlled smart nanocarrier with reversible polypeptide-engineered valve for targeted fluorescence-photoacoustic bimodal imaging-guided chemo-photothermal therapy. Theranostics. 2019; 9(25):7666-7679. PMC: 6831479. DOI: 10.7150/thno.37047. View